AgroPages-PhaseRx announces technology evaluation agreement with Monsanto-Agricultural news

PhaseRx, Inc., a privately held RNAi delivery technology company, announced today that it has signed a funded technology evaluation agreement with Monsanto Company for PhaseRx's delivery technologies. Through the agreement, Monsanto will evaluate PhaseRx's SMARTT Polymer Technology® for potential agricultural applications. Terms of the agreement were not disclosed.

"This agreement with Monsanto represents PhaseRx's first project in the large and growing field of agriculture," said Robert Overell, Ph.D., President and Chief Executive Officer of PhaseRx, Inc. "It also helps further validate the breadth of PhaseRx platform capabilities beyond our primary focus applications."

Subscribe Email:		*
Name:
Mobile Number:

A Deep exploration into Regulatory Analysis, Join upcoming <2024 CROs & CRAOs Manual>Magazine

Last Chance to Show Your Technology and Product in the Upcoming 2024 Formulation & Adjuvant Technology MagazineMagazine

BioEx 2024 successfully held: Biological innovation leading the way towards sustainable agricultureEvent

PhaseRx announces technology evaluation agreement with Monsanto

More from AgroNewsChange

Magazine

Hot Topic More

NEWSLETTER